Temozolomide
- Product NDC
- 65162-803
- 11-digit product format
- 651620803
- Labeler code
- 65162
- Product ID
- 65162-803_7cf62d84-45c0-405c-975b-3dbcbcf5ee27
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Temozolomide
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Amneal Pharmaceuticals LLC
- Application
- ANDA203691
- Marketing category
- ANDA
- Marketing start
- 2015-04-03
- Substance
- TEMOZOLOMIDE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Alkylating Activity [MoA], Alkylating Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Temozolomide
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| TEMOZOLOMIDE | 100 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | YF1K15M17Y |
| Rxcui | 313209, 313210, 313211, 317160, 700883, 700885 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 65162-803-14 | Temozolomide | 1 in 1 CARTON | CAPSULE | 1 | | 26 |
| 65162-803-14 | Temozolomide | 14 in 1 BOTTLE | CAPSULE | 14 | | 26 |
| 65162-803-51 | Temozolomide | 1 in 1 CARTON | CAPSULE | 1 | | 26 |
| 65162-803-51 | Temozolomide | 5 in 1 BOTTLE | CAPSULE | 5 | | 26 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| TEMOZOLOMIDE | ACTIVE INGREDIENT | YF1K15M17Y | TEMOZOLOMIDE CAPSULE [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 10 | |
| TEMOZOLOMIDE | ACTIVE MOIETY | YF1K15M17Y | TEMOZOLOMIDE CAPSULE [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 10 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | TEMOZOLOMIDE CAPSULE [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 10 | |
| ANHYDROUS LACTOSE | INACTIVE INGREDIENT | 3SY5LH9PMK | TEMOZOLOMIDE CAPSULE [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 10 | |
| BUTYL ALCOHOL | INACTIVE INGREDIENT | 8PJ61P6TS3 | TEMOZOLOMIDE CAPSULE [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 10 | |
| D&C YELLOW NO. 10 | INACTIVE INGREDIENT | 35SW5USQ3G | TEMOZOLOMIDE CAPSULE [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 10 | |
| FD&C BLUE NO. 1 | INACTIVE INGREDIENT | H3R47K3TBD | TEMOZOLOMIDE CAPSULE [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 10 | |
| FD&C BLUE NO. 2 | INACTIVE INGREDIENT | L06K8R7DQK | TEMOZOLOMIDE CAPSULE [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 10 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | TEMOZOLOMIDE CAPSULE [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 10 | |
| FD&C RED NO. 40 | INACTIVE INGREDIENT | WZB9127XOA | TEMOZOLOMIDE CAPSULE [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 10 | |
| FD&C YELLOW NO. 6 | INACTIVE INGREDIENT | H77VEI93A8 | TEMOZOLOMIDE CAPSULE [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 10 | |
| FERRIC OXIDE YELLOW | INACTIVE INGREDIENT | EX438O2MRT | TEMOZOLOMIDE CAPSULE [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 10 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | TEMOZOLOMIDE CAPSULE [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 10 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | TEMOZOLOMIDE CAPSULE [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 10 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | TEMOZOLOMIDE CAPSULE [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 10 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | TEMOZOLOMIDE CAPSULE [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 10 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | TEMOZOLOMIDE CAPSULE [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 10 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | TEMOZOLOMIDE CAPSULE [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 10 | |
| STEARIC ACID | INACTIVE INGREDIENT | 4ELV7Z65AP | TEMOZOLOMIDE CAPSULE [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 10 | |
| TARTARIC ACID | INACTIVE INGREDIENT | W4888I119H | TEMOZOLOMIDE CAPSULE [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 10 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | TEMOZOLOMIDE CAPSULE [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 10 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 65162-803 | TEMOZOLOMIDE CAPSULE [AMNEAL PHARMACEUTICALS LLC] | 26 | Current NDC, Legacy NDC, 4 package rows | 20250124_6c8529ec-8936-4fec-a1a5-2b285c7e4859.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 65162-803-14 | 65162080314 | 1 BOTTLE in 1 CARTON (65162-803-14) / 14 CAPSULE in 1 BOTTLE | 1 bottle | 2015-04-03 | 0000-00-00 | No | No | Current |
| 65162-803-51 | 65162080351 | 1 BOTTLE in 1 CARTON (65162-803-51) / 5 CAPSULE in 1 BOTTLE | 1 bottle | 2015-04-03 | 0000-00-00 | No | No | Current |